The aim of this study was to evaluate the effects of mediterranean and low-fat diet on hepatic fat, inflammation markers and oxidative stress in adolescents with nonalcoholic fatty liver disease. This randomized, single-blind controlled study conducted with obese adolescents aged 11-18 years who were admitted to Tepecik Training and Research Hospital Pediatric Gastroenterology Outpatient Clinic with the diagnosis of nonalcoholic fatty liver disease. Participants were randomly assigned to the Mediterranean diet or low-fat diet group.
This study was conducted to evaluate the effect of Mediterranean and low-fat diet on hepatic fat, inflammation and oxidative stress in obese adolescents with nonalcoholic fatty liver disease (NAFLD). The study, which was designed as a single blind randomized control, was completed with 44 obese adolescents diagnosed with NAFLD between the ages of 11-18. Adolescents were randomized to either a Mediterranean diet (n = 22) or a low-fat diet (control diet) (n = 22) for 12 weeks. At the beginning of the study and at the 12th week, adolescents' blood samples, physical activity and food consumption records were taken, anthropometric measurements and body composition analyzes were made, and antioxidant food consumption frequency and Mediterranean diet quality index questionnaire were applied to adolescents. In the controls performed at the 2th, 4th, 6th, 8th, and 10th weeks, the physical activity and food consumption records of the adolescents were repeated and anthropometric measurements and body composition analyzes were made again.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
44
Diet intervention:Mediterranean diet
Low fat diet
İzmir Tepecik Training and Research Hospital
Izmir, Turkey (Türkiye)
Changes in hepatic steatosis
Hepatic steatosis was evaluated according to liver ultrasonography records during the routine controls of all patients.
Time frame: Baseline and week 12
Changes in Inflammatory Parameters
Measurement of serum cytokines levels (C-reaktive protein (CRP), IL-10, IL-6, IL-8, IL-1 beta, TNF-alpha
Time frame: Baseline and week 12
Changes in oxidative stress markers
Measurement of oxidative stress markers (Total Antioxidant Status (TAS), Total Oxidant Status (TOS), Paraoxonase Enzyme Activity (PON-1), Total Thiol, Native Thiol, Superoxide Dismutase (SOD), oxidized-LDL, Glutathione peroxidase,Malondialdehyde (MDA), Glutathione (GSH), non-esterified fatty acids (NEFA))
Time frame: Baseline and week 12
Changes in glycemic profile
Measurement of fasting glucose, insulin, HbA1c and calculation of HOMA-IR
Time frame: Baseline and week 12
Changes in liver function tests
Measurement of Alanine transaminase (ALT),Aspartate transaminase (AST),Gamma-glutamyltransferase (GGT),Alkaline phosphatase (ALP)
Time frame: Baseline and week 12
Changes in serum cholesterol levels
Measurement of total cholesterol, LDL, HDL cholesterol
Time frame: Baseline and week 12
Changes in triglycerides
Measurement of serum triglyceride (mg/dl)
Time frame: Baseline and week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Changes in blood pressure
Measurement of systolic and diastolic blood pressure (mm Hg)
Time frame: Baseline and week 12
Changes in waist, hip and neck circumference
Measurement of waist circumference (cm)
Time frame: baseline, week 2, week 4, week 6, week 8, week 10 and week 12
Changes in Body Fat
Measurement of % body fat with BIA
Time frame: baseline, week 2, week 4, week 6, week 8, week 10 and week 12
Changes in BMI
weight and height will be measured to report BMI in kg/m2
Time frame: baseline, week 2, week 4, week 6, week 8, week 10 and week 12
Changes in some adipokines
Measurement of serum leptin and adiponectin
Time frame: Baseline and week 12